Bicocca Open Archive

Logo unimib boa
REDAELLI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.078
AS - Asia 3.870
EU - Europa 3.846
SA - Sud America 569
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 102
OC - Oceania 12
Totale 16.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.699
SG - Singapore 1.402
CN - Cina 893
IT - Italia 853
DE - Germania 751
VN - Vietnam 523
RU - Federazione Russa 474
BR - Brasile 421
HK - Hong Kong 406
SE - Svezia 392
IE - Irlanda 379
CA - Canada 319
UA - Ucraina 240
GB - Regno Unito 220
FR - Francia 169
IN - India 148
FI - Finlandia 100
BD - Bangladesh 73
TR - Turchia 73
AR - Argentina 56
PL - Polonia 52
IQ - Iraq 51
KR - Corea 50
ES - Italia 45
ZA - Sudafrica 40
ID - Indonesia 38
NL - Olanda 36
JP - Giappone 35
BE - Belgio 34
PK - Pakistan 33
MX - Messico 29
AT - Austria 28
DK - Danimarca 27
CO - Colombia 23
VE - Venezuela 22
SA - Arabia Saudita 21
EC - Ecuador 17
UZ - Uzbekistan 16
PH - Filippine 15
AU - Australia 11
MA - Marocco 11
AZ - Azerbaigian 10
CL - Cile 10
JO - Giordania 10
KE - Kenya 10
EU - Europa 9
IR - Iran 9
EG - Egitto 8
ET - Etiopia 8
LT - Lituania 8
TN - Tunisia 8
BG - Bulgaria 7
MY - Malesia 7
NP - Nepal 7
PY - Paraguay 7
TH - Thailandia 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
OM - Oman 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
GE - Georgia 4
IL - Israele 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
CR - Costa Rica 2
DZ - Algeria 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 16.471
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.126
Singapore 830
Ashburn 822
Woodbridge 589
San Jose 458
Fairfield 455
Hong Kong 396
Frankfurt am Main 386
Chandler 372
Dublin 367
Milan 343
Houston 314
Wilmington 259
Dearborn 235
Jacksonville 227
Toronto 209
Seattle 189
New York 185
Ho Chi Minh City 147
Beijing 143
Los Angeles 140
Cambridge 137
Dallas 127
Santa Clara 118
Hanoi 113
The Dalles 104
Princeton 101
Chicago 85
Shanghai 80
Göttingen 75
Nanjing 73
Hefei 64
Munich 63
Boardman 57
Lauterbourg 54
Altamura 49
Seoul 43
São Paulo 43
Lawrence 42
Moscow 39
Buffalo 37
Lachine 37
Rome 36
Council Bluffs 35
Brussels 34
Helsinki 32
London 31
Warsaw 30
Da Nang 29
Nanchang 29
Tokyo 29
Dong Ket 26
Jakarta 26
San Diego 26
Fremont 25
Fürstenwalde 25
Shenyang 25
Guangzhou 23
Orem 22
Turku 22
Johannesburg 21
Tianjin 21
Chennai 20
Vienna 20
Brooklyn 19
Montreal 19
Nuremberg 19
Andover 18
Changsha 18
Haiphong 18
Ottawa 18
Atlanta 17
Denver 17
Salt Lake City 17
Falls Church 16
Rio de Janeiro 16
Baghdad 15
Jiaxing 15
Lodz 15
Pune 15
Düsseldorf 14
Hangzhou 14
Jinan 14
Manchester 14
Mumbai 14
Philadelphia 14
Tashkent 14
Kocaeli 13
Lissone 13
Romola 13
San Francisco 13
Washington 13
Ankara 12
Buenos Aires 12
Hebei 12
Monza 12
Stockholm 12
Belo Horizonte 11
Boston 11
Figino 11
Totale 10.848
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 618
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 551
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 454
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 424
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 413
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 405
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 389
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 388
Idiopathic erythrocytosis: a germline disease? 383
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 381
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 375
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 364
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 364
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 350
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 340
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 338
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 336
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 335
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 332
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 329
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 325
Inhibition of RET tyrosine kinase by SU5416 324
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 320
Dual kinase targeting in leukemia 319
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 310
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 310
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 306
Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling 300
Reply to P. Laneuville et al 296
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 295
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 290
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 288
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 283
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 281
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 278
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 277
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 275
Expression, purification, and inhibition of human RET tyrosine kinase 273
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 268
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 265
BCR and BCR/ABL Regulation during Myeloid Differentiation in Healthy Donors and in Chronic Phase/Blast Crisis CML Patients 258
Novel targeted therapeutics for MEN2 243
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 239
Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein 237
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 232
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 230
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 230
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion 229
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 225
Volatile Sedation for Acute Respiratory Distress Syndrome Patients on Venovenous Extracorporeal Membrane Oxygenation and Ultraprotective Ventilation 219
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 209
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 191
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 187
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform InfraRed microspectroscopy and unsupervised Hierarchical Cluster Analysis. 171
Totale 16.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022755 53 77 83 47 51 70 38 34 37 81 64 120
2022/20231.491 169 461 145 151 93 197 18 81 84 23 33 36
2023/20241.066 28 34 43 60 139 299 217 38 54 23 15 116
2024/20252.250 141 224 153 129 203 72 151 89 194 378 196 320
2025/20265.911 693 283 487 623 747 285 846 224 466 565 343 349
2026/2027133 133 0 0 0 0 0 0 0 0 0 0 0
Totale 16.852